Clinical Trial

Trial Protocol ID USOR 24126_BDTX-1535-101 *STAR*

Trial Description

A Phase 1/2 Study to Assess BDTX-1535, an Oral EGFR Inhibitor, in Patients with Glioblastoma or Non-Small Cell Lung Cancer (BDTX-1535-101)

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Disease Types

Sponsor

  • Black Diamond Therapeutics